NCT04970966View on ClinicalTrials.gov

Efficacy of PuraSinus Versus Bioresorbable Nasal Dressings

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 1, 2022

Primary Completion Date

April 15, 2024

Study Completion Date

May 5, 2024

Conditions
Chronic Sinus DiseaseSurgery
Interventions
DEVICE

PuraSinus

A randomized ethmoid cavity in the patient will have PuraSinus applied to the ethmoid cavity after completion of an endoscopic total ethmoidectomy.

DEVICE

Bioresorbable Nasal Dressing

PosiSep X will be applied to the ethmoid cavity after completion of an endoscopic total ethmoidectomy.

Trial Locations (1)

90033

Keck Medical Center, Los Angeles

All Listed Sponsors
collaborator

Northwestern University

OTHER

lead

University of Southern California

OTHER

NCT04970966 - Efficacy of PuraSinus Versus Bioresorbable Nasal Dressings | Biotech Hunter | Biotech Hunter